P. Harris

发表

Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.

M. Korbonits, A. Grossman, F. Claret, 2002, The Journal of clinical endocrinology and metabolism.

Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.

J. Svensson, P. Harris, M. Kołtowska-Häggström, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The GnRH test in the assessment of patients with pituitary and parapituitary lesions: results of a 5-year retrospective study

P. Harris, S. Chambers, N. Chammas, 2004, Pituitary.

Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

M. Vance, W. Drake, D. Clemmons, 2005, The Journal of clinical endocrinology and metabolism.

Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression.

P. Harris, S. Hurel, W. Kelly, 1997, The Journal of clinical endocrinology and metabolism.

G protein and thyrotropin receptor mutations in thyroid neoplasia.

C. Esapa, J. Jameson, P. Harris, 1997, The Journal of clinical endocrinology and metabolism.

The Treatment of De Novo Acromegalic Patients with Octreotide-LAR: Efficacy, Tolerability and Cardiovascular Effects

P. Harris, M. Monaghan, P. Kane, 2004, Pituitary.

Prevalence of Ras mutations in thyroid neoplasia

C. Esapa, P. Harris, P. Kendall‐Taylor, 1999, Clinical endocrinology.

Genetic studies of a family with hereditary hyperparathyroidism–jaw tumour syndrome

C. Larsson, P. Harris, T. Peters, 1999, Clinical endocrinology.

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

P M Stewart, J M Wardlaw, P E Harris, 2002, The Journal of clinical endocrinology and metabolism.

Dynamic regulation of follicle-stimulating hormone-beta messenger ribonucleic acid levels by activin and gonadotropin-releasing hormone in perifused rat pituitary cells.

W. Crowley, J. Jameson, P. Harris, 1992, Endocrinology.

Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.

E. Hedley‐Whyte, A. Klibanski, J. Jameson, 1992, The Journal of clinical endocrinology and metabolism.

IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA

T. Chard, D. Lowe, P. Coates, 1988, Clinical endocrinology.

Growth hormone responses to growth hormone-releasing factor (1-29) in euthyroid, hypothyroid and hyperthyroid rats.

P. Harris, M. Rodríguez-Arnao, C. Diéguez, 1986, The Journal of endocrinology.

A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis.

C. Esapa, P. Harris, G. Vassart, 1999, Thyroid : official journal of the American Thyroid Association.

Hemochromatosis mutations C282Y and H63D in ‘cis’ phase

P. Harris, E. Spriggs, L. Best, 2001, Clinical genetics.

Reply: Ectopic ACTH syndrome: a diagnostic challenge!

P. Harris, P. Kane, M. Buxton-Thomas, 2001 .

G‐protein mutations in human pituitary adrenocorticotrophic hormone‐secreting adenomas

D. Harrison, P. Harris, P. Ince, 1995, European journal of clinical investigation.

The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?

P. Harris, K. Zhernosekov, 2022, Frontiers in Endocrinology.

Potential pathogenicity of autoantibodies to thyrotropin receptor in treated, euthyroid patients with Graves' disease.

J. Banga, P. Harris, 1998, European journal of endocrinology.

Gsα and Gi2α mutations in clinically non‐functioning pituitary tumours

P. Harris, M. Daniels, W. Kelly, 1994 .

Corticotroph Carcinoma Presenting as a Silent Corticotroph Adenoma

W. Farrell, R. Clayton, P. Harris, 2004, Pituitary.

Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours.

C. Esapa, P. Harris, 1999, European journal of endocrinology.

Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency

D. Dunger, P. Murgatroyd, J. Frystyk, 2005 .

Pre- and post‐treatment distribution pattern of 123I‐MIBG in patients with phaeochromocytomas and paragangliomas

P. Harris, A. Sinclair, K. Britton, 1989, Nuclear medicine communications.

Isolated aldosterone deficiency in a patient with autoimmune adrenalitis.

P. Harris, P. Kendall‐Taylor, 1991, The American journal of medicine.

Corticosteroid therapy in Riedel's thyroiditis.

P. Harris, B. Vaidya, P. Kendall‐Taylor, 1997, Postgraduate medical journal.

Hypogonadism caused by a single amino acid substitution in the β subunit of luteinizing hormone

W. Crowley, J. Jameson, P. Harris, 1992 .

Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone.

W. Crowley, J. Jameson, P. Harris, 1992, The New England journal of medicine.

Biochemical markers for clinically non‐functioning pituitary tumours

P. Harris, 1998, Clinical endocrinology.

Human pituitary adenomas do not overexpress thec-erbB-2 oncoprotein

P. Harris, P. Ince, M. Daniels, 1991, Endocrine Pathology.

A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

C. Larsson, C. J. Pearce, B. Teh, 1998, American journal of human genetics.

G protein gene mutations in patients with multiple endocrinopathies.

P. Harris, P. Kendall‐Taylor, E. Williamson, 1995, The Journal of clinical endocrinology and metabolism.

Clinical and genetic changes in a case of a Cushing's carcinoma

P. Harris, 1995 .

Gs protein mutations and the pathogenesis and function of pituitary tumors.

P. Harris, 1996, Metabolism: clinical and experimental.

G Protein Mutations in Pituitary Tumors: A Study on Turkish Patients

C. Esapa, P. Harris, C. Nacar, 2003, Pituitary.

The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours.

P. Coates, A. Grossman, P. Harris, 1989, The Quarterly journal of medicine.

D. Dunger, P. Murgatroyd, J. Frystyk, 2005, Clinical endocrinology.

The management of thyroid cancer in adults: a review of new guidelines.

P. Harris, 2002, Clinical medicine.

SUCCESSFUL TREATMENT BY CHEMOTHERAPY FOR ACROMEGALY ASSOCIATED WITH ECTOPIC GROWTH HORMONE RELEASING HORMONE SECRETION FROM A CARCINOID TUMOUR

P. Harris, J. Wass, G. Besser, 1990, Clinical endocrinology.

Effects of insulin-like growth factor-II on growth hormone release from human somatotrophinoma cells in vitro.

P. Harris, M. Daniels, P. Kendall‐Taylor, 1991, The Journal of endocrinology.

Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.

P. Harris, M. Daniels, W. Kelly, 1994, Clinical endocrinology.

Effects of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro.

P. Harris, M. Daniels, P. Kendall‐Taylor, 1993, The Journal of endocrinology.